Life cycle assessment and costing of urine source separation: Focus on nonsteroidal anti-inflammatory drug removal

Water Research

Volumn 105, Issue , 2016, Pages 487-495

  Landry, Kelly A ^a   Boyer, Treavor H ^b  

^a University of Florida   (United States)

^b Arizona State University   (United States)

Author keywords

Ion exchange; Life cycle assessment; Life cycle costing; Nonsteroidal anti inflammatory drugs; Urine source separation; Wastewater treatment

Indexed keywords

BIOLOGICAL WATER TREATMENT; BODY FLUIDS; COSTS; DRUG PRODUCTS; ION EXCHANGE; LIFE CYCLE; METABOLITES; NUTRIENTS; OZONE; OZONE WATER TREATMENT; OZONIZATION; POTABLE WATER; RECLAMATION; SEPARATION; SEWAGE PUMPING PLANTS; TOXICITY; TRUCKS; WATER TREATMENT PLANTS;

BIOLOGICAL WASTE WATER TREATMENT; CENTRALISED; DECENTRALIZED TREATMENTS; LIFE CYCLE ASSESSMENT; LIFE CYCLE COSTING; NON-STEROIDAL ANTI-INFLAMMATORY DRUGS; NONSTEROIDAL ANTI-INFLAMMATORY DRUGS; STRUVITE PRECIPITATION; URINE SOURCE SEPARATION; VACUUM TRUCKS;

WASTEWATER TREATMENT;

DICLOFENAC; DRINKING WATER; IBUPROFEN; KETOPROFEN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OZONE; STRUVITE;

COST ANALYSIS; DRUG; ENVIRONMENTAL IMPACT; ION EXCHANGE; LIFE CYCLE ANALYSIS; POLLUTANT REMOVAL; POLLUTANT SOURCE; SEPARATION; STRUVITE; URINE; WASTEWATER; WATER TREATMENT;

ADSORPTION; ARTICLE; ECOTOXICITY; ELECTRICITY; ENVIRONMENTAL IMPACT; HUMAN; ION EXCHANGE; LIFE CYCLE ASSESSMENT; OZONATION; PRECIPITATION; PRIORITY JOURNAL; SEWER; URINALYSIS; WASTE COMPONENT REMOVAL; WASTE WATER MANAGEMENT; WASTE WATER TREATMENT PLANT; CHEMISTRY; ENVIRONMENT; SEWAGE; WASTE WATER;

DICLOFENAC; ENVIRONMENT; HUMANS; OZONE; WASTE DISPOSAL, FLUID; WASTE WATER;

EID: 84988640167     PISSN: 00431354     EISSN: 18792448     Source Type: Journal    
DOI: 10.1016/j.watres.2016.09.024     Document Type: Article

References (74)

1. Alfonsín, C., Hospido, A., Omil, F., Moreira, M.T., Feijoo, G., PPCPs in wastewater–update and calculation of characterization factors for their inclusion in LCA studies. J. Clean. Prod. 83 (2014), 245–255.
2. Althaus, H.J., Hischier, R., Osses, M., Life Cycle Inventories of Chemicals, Data v2.0. 2007.
3. Alvarino, T., Suarez, S., Lema, J.M., Omil, F., Understanding the removal mechanisms of PPCPs and the influence of main technological parameters in anaerobic UASB and aerobic CAS reactors. J. Hazard. Mater. 278 (2014), 506–513.
4. Andersson, J., Ekheden, Y., Kaj, L., Remberger, M., Woldegiorgis, A., Results from the Swedish National Screening Programme, 2005. Subreport 1: Antibiotics, Anti-inflammatory Substances, and Hormones. 2007.
5. Berndtsson, J.C., Experiences from the implementation of a urine separation system: goals, planning, reality. Build. Environ. 41:4 (2006), 427–437.
6. Blair, B., Nikolaus, A., Hedman, C., Klaper, R., Grundl, T., Evaluating the degradation, sorption, and negative mass balances of pharmaceuticals and personal care products during wastewater treatment. Chemosphere 134 (2015), 395–401.
7. Carballa, M., Fink, G., Omil, F., Lema, J.M., Ternes, T., Determination of the solid–water distribution coefficient (Kd) for pharmaceuticals, estrogens and musk fragrances in digested sludge. Water Res. 42:1–2 (2008), 287–295.
8. Choe, J.K., Mehnert, M.H., Guest, J.S., Strathmann, T.J., Werth, C.J., Comparative assessment of the environmental sustainability of existing and emerging perchlorate treatment technologies for drinking water. Environ. Sci. Technol. 47:9 (2013), 4644–4652.
9. Cook, S.M., VanDuinen, B.J., Love, N.G., Skerlos, S.J., Life cycle comparison of environmental emissions from three disposal options for unused pharmaceuticals. Environ. Sci. Technol. 46:10 (2012), 5535–5541.
10. Crittenden, J.C., Trussell, R.R., Hand, D.W., Howe, K.J., Tchobanoglous, G., MWH's Water Treatment: Principles and Design. 2012, Ecoinvent Centre (2015) http://www.ecoinvent.org/database/database.html.
11. Ecoinvent Centre (2015), http://www.ecoinvent.org/database.html.
12. Fernandez-Fontaina, E., Omil, F., Lema, J.M., Carballa, M., Influence of nitrifying conditions on the biodegradation and sorption of emerging micropollutants. Water Res. 46:16 (2012), 5434–5444.
13. Finkbeiner, M., Ackermann, R., Bach, V., Berger, M., Brankatschk, G., Chang, Y.-J., Grinberg, M., Lehmann, A., Martínez-Blanco, J., Minkov, N., Neugebauer, S., Scheumann, R., Schneider, L., Wolf, K., Klöpffer, W., (eds.) Background and Future Prospects in Life Cycle Assessment, 2014, Springer Netherlands, Dordrecht, 207–258.
14. Forrest, A., Fattah, K., Mavinic, D., Koch, F., Optimizing struvite production for phosphate recovery in WWTP. J. Environ. Eng. 134:5 (2008), 395–402.
15. 2 emissions Profile of the U.S. Cement Industry. 2004 Washington D.C., 2004 https://www3.epa.gov/ttnchie1/conference/ei13/ghg/hanle.pdf.
16. Hauschild, M., McKone, T., Van de Meent, D., Huijbregts, M., Margni, M., Rosenbaum, R.K., Jolliet, O., Fantke, P., USEtox 2.0. 2015.
17. Hernando, M.D., Mezcua, M., Fernández-Alba, A.R., Barceló, D., Environmental risk assessment of pharmaceutical residues in wastewater effluents, surface waters and sediments. Talanta 69:2 (2006), 334–342.
18. Hollender, J., Zimmermann, S., Koepke, S., Krauss, M., McArdell, C., Ort, C., Singer, H., von Gunten, U., Siegrist, H., Elimination of organic micropollutants in a municipal wastewater treatment plant upgraded with a full-scale post-ozonation followed by sand filtration. Environ. Sci. Technol. 43:20 (2009), 7862–7869.
19. Igos, E., Benetto, E., Venditti, S., Kohler, C., Cornelissen, A., Comparative and integrative environmental assessment of advanced wastewater treatment processes based on an average removal of pharmaceuticals. Water Sci. Technol., 67(2), 2013.
20. Igos, E., Benetto, E., Venditti, S., Kohler, C., Cornelissen, A., Moeller, R., Biwer, A., Is it better to remove pharmaceuticals in decentralized or conventional wastewater treatment plants? A life cycle assessment comparison. Sci. Total Environ. 438:0 (2012), 533–540.
21. Ishii, S.K.L., Boyer, T.H., Life cycle comparison of centralized wastewater treatment and urine source separation with struvite precipitation: focus on urine nutrient management. Water Res. 79 (2015), 88–103.
22. Ishii, S.K.L., Boyer, T.H., Student support and perceptions of urine source separation in a university community. Water Res. 100 (2016), 146–156.
23. Jelic, A., Gros, M., Ginebreda, A., Cespedes-Sánchez, R., Ventura, F., Petrovic, M., Barcelo, D., Occurrence, partition and removal of pharmaceuticals in sewage water and sludge during wastewater treatment. Water Res. 45:3 (2011), 1165–1176.
24. Jimenez, J., Bott, C., Love, N., Bratby, J., Source separation of urine as an alternative solution to nutrient management in biological nutrient removal treatment plants. Water Environ. Res. 87:12 (2015), 2120–2129.
25. Jones, O.A.H., Voulvoulis, N., Lester, J.N., Aquatic environmental assessment of the top 25 English prescription pharmaceuticals. Water Res. 36:20 (2002), 5013–5022.
26. Joss, A., Keller, E., Alder, A., Gobel, A., McArdell, C., Ternes, T., Siegrist, H., Removal of pharmaceuticals and fragrances in biological wastewater treatment. Water Res. 39:14 (2005), 3139–3152.
27. Kirchmann, H., Pettersson, S., Human urine - chemical-composition and fertilizer use efficiency. Fertilizer Res. 40:2 (1995), 149–154.
28. Lam, L., Kurisu, K., Hanaki, K., Comparative environmental impacts of source-separation systems for domestic wastewater management in rural China. J. Clean. Prod. 104 (2015), 185–198.
29. Lamichhane, K., Babcock, R., An economic appraisal of using source separation of human urine to contain and treat endocrine disrupters in the USA. J. Environ. Monit. 14:10 (2012), 2557–2565.
30. Landry, K.A., Boyer, T.H., Diclofenac removal in urine using strong-base anion exchange polymer resins. Water Res. 47:17 (2013), 6432–6444.
31. Landry, K.A., Sun, P., Huang, C.-H., Boyer, T.H., Ion-exchange selectivity of diclofenac, ibuprofen, ketoprofen, and naproxen in ureolyzed human urine. Water Res. 68:0 (2015), 510–521.
32. Larsen, T., Gujer, W., Separate management of anthropogenic nutrient solutions (human urine). Water Sci. Technol. 34:3–4 (1996), 87–94.
33. Lienert, J., Burki, T., Escher, B., Reducing micropollutants with source control: substance flow analysis of 212 pharmaceuticals in faeces and urine. Water Sci. Technol. 56:5 (2007), 87–96.
34. Lienert, J., Gudel, K., Escher, B., Screening method for ecotoxicological hazard assessment of 42 pharmaceuticals considering human metabolism and excretory routes. Environ. Sci. Technol. 41:12 (2007), 4471–4478.
35. Lienert, J., Haller, M., Berner, A., Stauffacher, M., Larsen, T.A., How farmers in Switzerland perceive fertilizers from recycled anthropogenic nutrients (urine). Water Sci. Technol. 48:1 (2003), 47–56.
36. Lienert, J., Larsen, T.A., High acceptance of urine source separation in seven European countries: a review. Environ. Sci. Technol. 44:2 (2010), 556–566.
37. Lindqvist, N., Tuhkanen, T., Kronberg, L., Occurrence of acidic pharmaceuticals in raw and treated sewages and in receiving waters. Water Res. 39:11 (2005), 2219–2228.
38. Lu, M.-C., Chen, Y.Y., Chiou, M.-R., Chen, M.Y., Fan, H.-J., Occurrence and treatment efficiency of pharmaceuticals in landfill leachates. Waste Manag. 55 (2016), 257–264.
39. Lugon-Moulin, N., Ryan, L., Donini, P., Rossi, L., Cadmium content of phosphate fertilizers used for tobacco production. Agron. Sustain. Dev. 26:3 (2006), 151–155.
40. Magdeburg, A., Stalter, D., Oehlmann, J., Whole effluent toxicity assessment at a wastewater treatment plant upgraded with a full-scale post-ozonation using aquatic key species. Chemosphere 88:8 (2012), 1008–1014.
41. Margot, J., Kienle, C., Magnet, A., Weil, M., Rossi, L., de Alencastro, L.F., Abegglen, C., Thonney, D., Chèvre, N., Schärer, M., Barry, D.A., Treatment of micropollutants in municipal wastewater: ozone or powdered activated carbon?. Sci. Total Environ. 461–462 (2013), 480–498.
42. Maul, G.A., Kim, Y., Amini, A., Zhang, Q., Boyer, T.H., Efficiency and life cycle environmental impacts of ion-exchange regeneration using sodium, potassium, chloride, and bicarbonate salts. Chem. Eng. J. 254:0 (2014), 198–209.
43. Maurer, M., Schwegler, P., Larsen, T.A., Nutrients in urine: energetic aspects of removal and recovery. Water Sci. Technol. 48:1 (2003), 37–46.
44. McClellan, K., Halden, R.U., Pharmaceuticals and personal care products in archived U.S. Biosolids from the 2001 EPA national sewage sludge survey. Water Res. 44:2 (2010), 658–668.
45. Morais, S.A., Multimedia Fate Modelling and Impact of Pharmaceutical Compounds on Freshwater Ecosystems. 2014.
46. Muñoz, I., José Gómez, M., Molina-Díaz, A., Huijbregts, M.A.J., Fernández-Alba, A.R., García-Calvo, E., Ranking potential impacts of priority and emerging pollutants in urban wastewater through life cycle impact assessment. Chemosphere 74:1 (2008), 37–44.
47. Muñoz, I., Rodríguez, A., Rosal, R., Fernández-Alba, A.R., Life Cycle Assessment of urban wastewater reuse with ozonation as tertiary treatment: a focus on toxicity-related impacts. Sci. Total Environ. 407:4 (2009), 1245–1256.
48. National Center for Environmental Economics, Guidelines for Preparing Economic Analyses. 2010, U.S. Environmental Protection Agency https://yosemite.epa.gov/ee/epa/eerm.nsf/vwAN/EE-0568-50.pdf/$file/EE-0568-50.pdf.
49. Nemecek, T., Kägi, T., Life Cycle Inventories of Agricultural Production Systems, Data v2.0. 2007, Ecoinvent Centre, Zurich and Dubendorf.
50. NREL, U.S. Life Cycle Inventory Database. 2012 https://www.lcacommons.gov/nrel/search.
51. Ort, C., Lawrence, M.G., Reungoat, J., Eaglesham, G., Carter, S., Keller, J., Determining the fraction of pharmaceutical residues in wastewater originating from a hospital. Water Res. 44:2 (2010), 605–615.
52. Pomati, F., Orlandi, C., Clerici, M., Luciani, F., Zuccato, E., Effects and interactions in an environmentally relevant mixture of pharmaceuticals. Toxicol. Sci. 102:1 (2008), 129–137.
53. PRé Consultants, 2014 http://www.pre-sustainability.com/.
54. Radjenović, J., Petrović, M., Barceló, D., Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment. Water Res. 43:3 (2009), 831–841.
55. Ramos, T.R.P., Gomes, M.I., Barbosa-Póvoa, A.P., Planning a sustainable reverse logistics system: balancing costs with environmental and social concerns. Omega 48 (2014), 60–74.
56. Remy, C., Life Cycle Assessment of Conventional and Source-separation Systems for Urban Wastewater Management. Ph.D. Dissertation, 2010, Technische Universität, Berlin.
57. Rivera-Utrilla, J., Sánchez-Polo, M., Ferro-García, M.Á., Prados-Joya, G., Ocampo-Pérez, R., Pharmaceuticals as emerging contaminants and their removal from water. A review. Chemosphere 93:7 (2013), 1268–1287.
58. Ronteltap, M., Maurer, M., Gujer, W., The behaviour of pharmaceuticals and heavy metals during struvite precipitation in urine. Water Res. 41:9 (2007), 1859–1868.
59. Rosal, R., Rodríguez, A., Perdigón-Melón, J.A., Petre, A., García-Calvo, E., Gómez, M.J., Agüera, A., Fernández-Alba, A.R., Occurrence of emerging pollutants in urban wastewater and their removal through biological treatment followed by ozonation. Water Res. 44:2 (2010), 578–588.
60. Ryberg, M., Vieira, M.M., Zgola, M., Bare, J., Rosenbaum, R., Updated US and Canadian normalization factors for TRACI 2.1. Clean Technol. Environ. Policy 16:2 (2014), 329–339.
61. Salgado, R., Marques, R., Noronha, J., Carvalho, G., Oehmen, A., Reis, M., Assessing the removal of pharmaceuticals and personal care products in a full-scale activated sludge plant. Environ. Sci. Pollut. Res. 19:5 (2012), 1818–1827.
62. Sánchez-Polo, M., Rivera-Utrilla, J., Prados-Joya, G., Ferro-García, M.A., Bautista-Toledo, I., Removal of pharmaceutical compounds, nitroimidazoles, from waters by using the ozone/carbon system. Water Res. 42:15 (2008), 4163–4171.
63. Seyler, C., Hellweg, S., Monteil, M., Hungerbühler, K., Life cycle inventory for use of waste solvent as fuel substitute in the cement industry - a multi-input allocation model (11 pp). Int. J. Life Cycle Assess. 10:2 (2005), 120–130.
64. Sipma, J., Osuna, B., Collado, N., Monclús, H., Ferrero, G., Comas, J., Rodriguez-Roda, I., Comparison of removal of pharmaceuticals in MBR and activated sludge systems. Desalination 250:2 (2010), 653–659.
65. Stalter, D., Magdeburg, A., Weil, M., Knacker, T., Oehlmann, J., Toxication or detoxication? In vivo toxicity assessment of ozonation as advanced wastewater treatment with the rainbow trout. Water Res. 44:2 (2010), 439–448.
66. Ternes, T.A., Occurrence of drugs in German sewage treatment plants and rivers. Water Res. 32:11 (1998), 3245–3260.
67. Ternes, T.A., Stüber, J., Herrmann, N., McDowell, D., Ried, A., Kampmann, M., Teiser, B., Ozonation: a tool for removal of pharmaceuticals, contrast media and musk fragrances from wastewater?. Water Res. 37:8 (2003), 1976–1982.
68. U.S. EPA, Tool for the Reduction and Assessment of Chemical and Other Environmental Impacts. 2014 http://www.epa.gov/nrmrl/std/traci/traci.html.
69. Verlicchi, P., Al Aukidy, M., Zambello, E., Occurrence of pharmaceutical compounds in urban wastewater: removal, mass load and environmental risk after a secondary treatment—A review. Sci. Total Environ. 429:0 (2012), 123–155.
70. Watanabe, H., Tamura, I., Abe, R., Takanobu, H., Nakamura, A., Suzuki, T., Hirose, A., Nishimura, T., Tatarazako, N., Chronic toxicity of an environmentally relevant mixture of pharmaceuticals to three aquatic organisms (alga, daphnid, and fish). Environ. Toxicol. Chem. 35:4 (2015), 996–1006.
71. Winker, M., Faika, D., Gulyas, H., Otterpohl, R., A comparison of human pharmaceutical concentrations in raw municipal wastewater and yellowwater. Sci. Total Environ. 399:1–3 (2008), 96–104.
72. Winker, M., Tettenborn, F., Faika, D., Gulyas, H., Otterpohl, R., Comparison of analytical and theoretical pharmaceutical concentrations in human urine in Germany. Water Res. 42:14 (2008), 3633–3640.
73. Wood, A., Blackhurst, M., Hawkins, T., Xue, X., Ashbolt, N., Garland, J., Cost-effectiveness of nitrogen mitigation by alternative household wastewater management technologies. J. Environ. Manag. 150 (2015), 344–354.
74. Zhang, R., Sun, P., Boyer, T.H., Zhao, L., Huang, C.-H., Degradation of pharmaceuticals and metabolite in synthetic human urine by UV, UV/H2O2, and UV/PDS. Environ. Sci. Technol. 49:5 (2015), 3056–3066.